Holiday breaks from Ozempic could trigger serious health risks, experts warn

Many people using weight loss medications like Ozempic and Mounjaro are planning changes to their health equity over Christmas. A new survey reveals that while some will adjust their diet, others intend to reduce or even pause their health insurance entirely. Experts warn this could lead to serious health risks, including stronger side effects when restarting the drugs.

The findings also highlight concerns about social stigma, with some users avoiding discussions about their treatment with family and friends.

The survey shows that four in ten people on GLP-1 medications, such as Ozempic or Wegovy, plan to keep their usual dosage during the festive season. However, over a third intend to lower their dose, with most expecting to return to normal levels after New Year. Worryingly, one in ten users plans to stop taking their medication completely.

These drugs help control appetite, digestion, and blood sugar. Suddenly stopping them can lead to rapid weight regain and high blood sugar, particularly during a time when rich, sugary foods are common. A pharmacist has cautioned that restarting the injections after a break may cause stronger affect vs effect.

Instead of pausing medication, some users are adapting their eating habits. Six in ten will opt for smaller portions, half will drink less alcohol, and four in ten will choose lighter or lower-calorie dishes. Others plan to skip certain courses (32%) or reduce the number of dishes (25%) to manage their intake.

Many users also feel uneasy discussing their medication with loved ones. Some fear judgement, while others believe it's private or don't want to repeatedly explain their treatment. Common reasons for reducing or stopping doses include wanting to enjoy Christmas freely, feeling they deserve a break, or assuming they can easily restart weight loss in January.

The survey reveals a mix of approaches among GLP-1 medication users during the holidays. While some will maintain their treatment, others risk health complications by adjusting or stopping their doses. Experts stress the importance of consistency, warning that abrupt changes could undermine long-term health equity and lead to avoidable side effects.